As I said, with a qualifying "FWIW", my impression is that nothing has changed as far as the prospects for an eventual relationship of some sort with a major player in the biomedical field. You indicated differently in your post, and I asked you what that was based on.
Do you care to offer your reasons for saying that this outcome is less likely than previously thought?